AGILYSYS INC (AGYS) Fundamental Analysis & Valuation

NASDAQ:AGYS • US00847J1051

79.75 USD
-0.26 (-0.32%)
At close: Mar 5, 2026
79.75 USD
0 (0%)
After Hours: 3/5/2026, 8:00:01 PM

This AGYS fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

6

AGYS gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 276 industry peers in the Software industry. While AGYS has a great profitability rating, there are some minor concerns on its financial health. AGYS is valued quite expensive, but it does show an excellent growth. These ratings could make AGYS a good candidate for growth investing.


Dividend Valuation Growth Profitability Health

7

1. AGYS Profitability Analysis

1.1 Basic Checks

  • In the past year AGYS was profitable.
  • AGYS had a positive operating cash flow in the past year.
  • Of the past 5 years AGYS 4 years were profitable.
  • In the past 5 years AGYS always reported a positive cash flow from operatings.
AGYS Yearly Net Income VS EBIT VS OCF VS FCFAGYS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20M -20M 40M 60M 80M

1.2 Ratios

  • AGYS has a Return On Assets of 6.40%. This is in the better half of the industry: AGYS outperforms 76.45% of its industry peers.
  • Looking at the Return On Equity, with a value of 9.72%, AGYS is in the better half of the industry, outperforming 73.91% of the companies in the same industry.
  • AGYS has a better Return On Invested Capital (7.91%) than 80.07% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for AGYS is below the industry average of 10.79%.
  • The 3 year average ROIC (7.16%) for AGYS is below the current ROIC(7.91%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 6.4%
ROE 9.72%
ROIC 7.91%
ROA(3y)11.61%
ROA(5y)4.91%
ROE(3y)17.82%
ROE(5y)7.29%
ROIC(3y)7.16%
ROIC(5y)N/A
AGYS Yearly ROA, ROE, ROICAGYS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 -40

1.3 Margins

  • Looking at the Profit Margin, with a value of 9.79%, AGYS is in the better half of the industry, outperforming 72.46% of the companies in the same industry.
  • AGYS's Profit Margin has improved in the last couple of years.
  • Looking at the Operating Margin, with a value of 9.71%, AGYS is in the better half of the industry, outperforming 76.09% of the companies in the same industry.
  • AGYS's Operating Margin has improved in the last couple of years.
  • Looking at the Gross Margin, with a value of 61.67%, AGYS is doing worse than 60.51% of the companies in the same industry.
  • In the last couple of years the Gross Margin of AGYS has grown nicely.
Industry RankSector Rank
OM 9.71%
PM (TTM) 9.79%
GM 61.67%
OM growth 3Y22.98%
OM growth 5YN/A
PM growth 3Y43.88%
PM growth 5YN/A
GM growth 3Y-0.01%
GM growth 5Y4.37%
AGYS Yearly Profit, Operating, Gross MarginsAGYS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40 60

6

2. AGYS Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), AGYS is destroying value.
  • Compared to 1 year ago, AGYS has more shares outstanding
  • AGYS has more shares outstanding than it did 5 years ago.
  • AGYS has a worse debt/assets ratio than last year.
AGYS Yearly Shares OutstandingAGYS Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M 20M 25M
AGYS Yearly Total Debt VS Total AssetsAGYS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M

2.2 Solvency

  • An Altman-Z score of 9.84 indicates that AGYS is not in any danger for bankruptcy at the moment.
  • With an excellent Altman-Z score value of 9.84, AGYS belongs to the best of the industry, outperforming 92.03% of the companies in the same industry.
  • AGYS has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 9.84
ROIC/WACC0.71
WACC11.08%
AGYS Yearly LT Debt VS Equity VS FCFAGYS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M 100M 150M 200M 250M

2.3 Liquidity

  • AGYS has a Current Ratio of 1.31. This is a normal value and indicates that AGYS is financially healthy and should not expect problems in meeting its short term obligations.
  • AGYS has a Current ratio of 1.31. This is in the lower half of the industry: AGYS underperforms 61.59% of its industry peers.
  • A Quick Ratio of 1.25 indicates that AGYS should not have too much problems paying its short term obligations.
  • AGYS has a Quick ratio of 1.25. This is in the lower half of the industry: AGYS underperforms 64.13% of its industry peers.
Industry RankSector Rank
Current Ratio 1.31
Quick Ratio 1.25
AGYS Yearly Current Assets VS Current LiabilitesAGYS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M

9

3. AGYS Growth Analysis

3.1 Past

  • AGYS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 26.12%, which is quite impressive.
  • Measured over the past years, AGYS shows a very strong growth in Earnings Per Share. The EPS has been growing by 47.96% on average per year.
  • AGYS shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 17.86%.
  • AGYS shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 11.38% yearly.
EPS 1Y (TTM)26.12%
EPS 3Y23.91%
EPS 5Y47.96%
EPS Q2Q%10.53%
Revenue 1Y (TTM)17.86%
Revenue growth 3Y19.23%
Revenue growth 5Y11.38%
Sales Q2Q%15.57%

3.2 Future

  • The Earnings Per Share is expected to grow by 21.38% on average over the next years. This is a very strong growth
  • Based on estimates for the next years, AGYS will show a very strong growth in Revenue. The Revenue will grow by 21.76% on average per year.
EPS Next Y6.32%
EPS Next 2Y18.73%
EPS Next 3Y21.38%
EPS Next 5YN/A
Revenue Next Year16.54%
Revenue Next 2Y15.44%
Revenue Next 3Y15.02%
Revenue Next 5Y21.76%

3.3 Evolution

  • Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
AGYS Yearly Revenue VS EstimatesAGYS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 200M 400M 600M 800M
AGYS Yearly EPS VS EstimatesAGYS Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 1 2

2

4. AGYS Valuation Analysis

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 47.19, the valuation of AGYS can be described as expensive.
  • The rest of the industry has a similar Price/Earnings ratio as AGYS.
  • When comparing the Price/Earnings ratio of AGYS to the average of the S&P500 Index (26.74), we can say AGYS is valued expensively.
  • Based on the Price/Forward Earnings ratio of 36.26, the valuation of AGYS can be described as expensive.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of AGYS is on the same level as its industry peers.
  • AGYS's Price/Forward Earnings ratio indicates a valuation a bit more expensive than the S&P500 average which is at 24.82.
Industry RankSector Rank
PE 47.19
Fwd PE 36.26
AGYS Price Earnings VS Forward Price EarningsAGYS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

  • The rest of the industry has a similar Enterprise Value to EBITDA ratio as AGYS.
  • AGYS's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 37.87
EV/EBITDA 53.71
AGYS Per share dataAGYS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
  • AGYS has a very decent profitability rating, which may justify a higher PE ratio.
  • AGYS's earnings are expected to grow with 21.38% in the coming years. This may justify a more expensive valuation.
PEG (NY)7.47
PEG (5Y)0.98
EPS Next 2Y18.73%
EPS Next 3Y21.38%

0

5. AGYS Dividend Analysis

5.1 Amount

  • No dividends for AGYS!.
Industry RankSector Rank
Dividend Yield 0%

AGYS Fundamentals: All Metrics, Ratios and Statistics

AGILYSYS INC

NASDAQ:AGYS (3/5/2026, 8:00:01 PM)

After market: 79.75 0 (0%)

79.75

-0.26 (-0.32%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)01-26
Earnings (Next)05-18
Inst Owners106.42%
Inst Owner Change-0.61%
Ins Owners4.27%
Ins Owner Change-0.22%
Market Cap2.24B
Revenue(TTM)310.64M
Net Income(TTM)30.42M
Analysts81.43
Price Target139.11 (74.43%)
Short Float %6.34%
Short Ratio5.23
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-3.76%
Min EPS beat(2)-9.64%
Max EPS beat(2)2.12%
EPS beat(4)2
Avg EPS beat(4)16.71%
Min EPS beat(4)-10.75%
Max EPS beat(4)85.11%
EPS beat(8)6
Avg EPS beat(8)14.3%
EPS beat(12)10
Avg EPS beat(12)18.27%
EPS beat(16)14
Avg EPS beat(16)20.42%
Revenue beat(2)1
Avg Revenue beat(2)0.44%
Min Revenue beat(2)-0.27%
Max Revenue beat(2)1.14%
Revenue beat(4)3
Avg Revenue beat(4)0.98%
Min Revenue beat(4)-0.27%
Max Revenue beat(4)1.95%
Revenue beat(8)3
Avg Revenue beat(8)-1.08%
Revenue beat(12)4
Avg Revenue beat(12)-0.78%
Revenue beat(16)8
Avg Revenue beat(16)0.02%
PT rev (1m)-2.39%
PT rev (3m)-1.21%
EPS NQ rev (1m)3.27%
EPS NQ rev (3m)4.69%
EPS NY rev (1m)-2.55%
EPS NY rev (3m)-2.15%
Revenue NQ rev (1m)0.08%
Revenue NQ rev (3m)0.72%
Revenue NY rev (1m)0.1%
Revenue NY rev (3m)0.97%
Valuation
Industry RankSector Rank
PE 47.19
Fwd PE 36.26
P/S 7.22
P/FCF 37.87
P/OCF 36.56
P/B 7.16
P/tB 20.66
EV/EBITDA 53.71
EPS(TTM)1.69
EY2.12%
EPS(NY)2.2
Fwd EY2.76%
FCF(TTM)2.11
FCFY2.64%
OCF(TTM)2.18
OCFY2.74%
SpS11.05
BVpS11.14
TBVpS3.86
PEG (NY)7.47
PEG (5Y)0.98
Graham Number20.58
Profitability
Industry RankSector Rank
ROA 6.4%
ROE 9.72%
ROCE 8.73%
ROIC 7.91%
ROICexc 10.35%
ROICexgc 46.15%
OM 9.71%
PM (TTM) 9.79%
GM 61.67%
FCFM 19.05%
ROA(3y)11.61%
ROA(5y)4.91%
ROE(3y)17.82%
ROE(5y)7.29%
ROIC(3y)7.16%
ROIC(5y)N/A
ROICexc(3y)15.95%
ROICexc(5y)N/A
ROICexgc(3y)439.05%
ROICexgc(5y)N/A
ROCE(3y)7.91%
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3Y-16.81%
ROICexc growth 5YN/A
OM growth 3Y22.98%
OM growth 5YN/A
PM growth 3Y43.88%
PM growth 5YN/A
GM growth 3Y-0.01%
GM growth 5Y4.37%
F-Score7
Asset Turnover0.65
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 20.82%
Cap/Sales 0.68%
Interest Coverage 250
Cash Conversion 151.93%
Profit Quality 194.56%
Current Ratio 1.31
Quick Ratio 1.25
Altman-Z 9.84
F-Score7
WACC11.08%
ROIC/WACC0.71
Cap/Depr(3y)131.65%
Cap/Depr(5y)90.98%
Cap/Sales(3y)2.69%
Cap/Sales(5y)1.97%
Profit Quality(3y)162.49%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)26.12%
EPS 3Y23.91%
EPS 5Y47.96%
EPS Q2Q%10.53%
EPS Next Y6.32%
EPS Next 2Y18.73%
EPS Next 3Y21.38%
EPS Next 5YN/A
Revenue 1Y (TTM)17.86%
Revenue growth 3Y19.23%
Revenue growth 5Y11.38%
Sales Q2Q%15.57%
Revenue Next Year16.54%
Revenue Next 2Y15.44%
Revenue Next 3Y15.02%
Revenue Next 5Y21.76%
EBIT growth 1Y16.97%
EBIT growth 3Y46.64%
EBIT growth 5YN/A
EBIT Next Year197.99%
EBIT Next 3Y68.08%
EBIT Next 5Y56.79%
FCF growth 1Y147.44%
FCF growth 3Y24.23%
FCF growth 5Y48.7%
OCF growth 1Y74.29%
OCF growth 3Y24.6%
OCF growth 5Y39.06%

AGILYSYS INC / AGYS FAQ

Can you provide the ChartMill fundamental rating for AGILYSYS INC?

ChartMill assigns a fundamental rating of 6 / 10 to AGYS.


What is the valuation status for AGYS stock?

ChartMill assigns a valuation rating of 2 / 10 to AGILYSYS INC (AGYS). This can be considered as Overvalued.


Can you provide the profitability details for AGILYSYS INC?

AGILYSYS INC (AGYS) has a profitability rating of 7 / 10.


How financially healthy is AGILYSYS INC?

The financial health rating of AGILYSYS INC (AGYS) is 6 / 10.


Can you provide the expected EPS growth for AGYS stock?

The Earnings per Share (EPS) of AGILYSYS INC (AGYS) is expected to grow by 6.32% in the next year.